627 - The Future of Biopharma: AI, Automation, and Clinical Trial Breakthroughs at BIO2026

In this episode of Talking HealthTech, Peter Birch speaks with Jayden Rogers (CEO, Linear Clinical Research), Dr Stacie Calad-Thomson (Business Development Lead, Nvidia for Pharma Labs and Manufacturing), Arjun Bhat (Co-Founder, Clinrol), and Tran Le (General Manager, Hippocratic AI).The conversations cover the changing landscape of clinical trials and drug discovery, the growing role of AI in patient recruitment and drug development, and innovations in technology and operational efficiency in life sciences.The discussion covers why Australia has become an attractive destination for global clinical trials, from its regulatory environment and world-class clinicians through to the integrated networks that help international sponsors find the right partners.It also looks at the practical realities of running a trial site, where regulatory approvals, staffing, patient engagement, and sensitive data all need to be managed at once, and how purpose-built platforms are taking on the repetitive work so research teams can focus on patient care.This episode was recorded during the BIO International Convention in San Diego, featuring conversations with scientists, founders, investors, and healthcare decision-makers addressing challenges and opportunities across the biotech sector.Key Takeaways🧬 AI and automation are transforming clinical trial recruitment, streamlining patient matching, eligibility screening, and follow-up tasks🚀 Australia’s reputation for clinical trials continues to grow, supported by a strong regulatory environment and quality healthcare ecosystem💡 Open source tools and AI models are making computational drug discovery more accessible for non-specialists in science and medicine🧑‍⚕️ Technology advancements allow clinicians and trial sites to focus more on patient care by reducing manual and repetitive efforts🔗 Collaboration across pharma, biotechs, technology providers, and regulators is essential to tackle operational bottlenecks and accelerate drug developmentTimestamps00:00 - Introduction01:07 - Jayden Rogers, CEO, Linear Clinical Research08:25 - Dr Stacie Calad-Thomson, Business Development, NVIDIA17:55 - Arjun Bhat, Co-Founder, Clinrol26:52 - Tran Le, General Manager of Life Sciences, Hippocratic AICheck out the episode and full show notes on the Talking HealthTech website.If you’re enjoying the show and want access to exclusive healthtech discussions, meetups, and member-only content, you can learn more about becoming a THT+ Solo Member here: talkinghealth.tech/solo_shownotesAnd if this episode was useful, leaving a review or sharing it with someone in the industry always helps.Mentioned in this episode:THT+ Company PartnershipLearn more about THT+ Company Partnership options for start-ups, scale-ups and enterprise digital health companies looking for visibility, content, community access and industry connection: talkinghealthtech.com/partners.THT+ Company PartnershipLearn more about THT+ Company Partnership options for start-ups, scale-ups and enterprise digital health companies looking for visibility, content, community access and industry connection: talkinghealthtech.com/partners.THT+ Company PartnershipLearn more about THT+ Company Partnership options for start-ups, scale-ups and enterprise digital health companies looking for visibility, content, community access and industry connection: talkinghealthtech.com/partners.